Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
10 Oct 2016 ESMO 2016 Press Release: Longer Disease-free Survival in Phase III Trial of Sunitinib as Adjuvant Treatment for Kidney Cancer Genitourinary cancers
10 Oct 2016 ESMO 2016: Metformin Significantly Lowers the Risk of Cancer Progression in Patients with Diabetes and Advanced pNETs Endocrine and neuroendocrine tumours - Anticancer agents & Biologic therapy
10 Oct 2016 ESMO 2016: The NETwork! Translational Programme Facilitates Genomic Analysis of Neuroendocrine Tumours Translational research - Endocrine and neuroendocrine tumours
10 Oct 2016 ESMO 2016: Clinical Benefit Demonstrated with Everolimus and Pasireotide LAR Alone or in Combination in the First Randomised, Prospective Study Entirely Dedicated to Advanced Lung and Thymic Carcinoids Endocrine and neuroendocrine tumours - Anticancer agents & Biologic therapy
10 Oct 2016 ESMO 2016: Meta-Analysis Confirms Superiority of Concomitant Over Induction Chemotherapy in Non-Metastatic HNSCC Head and neck cancers
10 Oct 2016 ESMO 2016: PD-L1 Expression as a Biomarker for Checkpoint Inhibitors Response in Patients with Advanced Melanoma Melanoma and other skin tumours - Cancer Immunology and Immunotherapy
10 Oct 2016 ESMO 2016: Baseline Genetic Features Elucidated in Responding and Non-Responding Patients with BRAFV600-Mutated Melanoma Translational research - Melanoma and other skin tumours
10 Oct 2016 ESMO 2016: ERBB2 Gene Alterations May Be Prognostic of Poorer Outcome in Stage III Colon Cancer Translational research - Gastrointestinal cancers
10 Oct 2016 ESMO 2016: Results of the First Cohort of Patients Screened Within the New EORTC Molecular Platform for Patients With Colorectal Cancer Translational research - Gastrointestinal cancers
10 Oct 2016 ESMO 2016 Press Release: Single-Arm Trials Improve Early Access to Rare Cancer Drugs Translational research
10 Oct 2016 ESMO 2016 Press Release: Cabozantinib Improves Progression-free Survival in Metastatic Renal Cell Carcinoma Genitourinary cancers
10 Oct 2016 ESMO 2016 Press Release: MEK Inhibition in KRAS-mutant NSCLC Did Not Improve Survival Lung and other thoracic tumours
10 Oct 2016 ESMO 2016 Press Release: Significant Survival Gains from Neoadjuvant Chemotherapy for High-risk Soft Tissue Sarcoma Sarcomas
10 Oct 2016 ESMO 2016 Press Release: Financial Difficulties Linked to Worse Outcomes From Cancer Treatment Bioethics, legal and economic issues
10 Oct 2016 ESMO 2016 Press Release: First Feasibility Study of the ESMO-MCBS Scale in Rare Tumour Entities Bioethics, legal and economic issues